115 related articles for article (PubMed ID: 15582444)
21. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety.
Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y
Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068
[TBL] [Abstract][Full Text] [Related]
22. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
23. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
[TBL] [Abstract][Full Text] [Related]
24. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
25. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895
[TBL] [Abstract][Full Text] [Related]
26. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
[TBL] [Abstract][Full Text] [Related]
27. Antiandrogenic natural Diels--Alder-type adducts from Brosimum rubescens.
Shirota O; Takizawa K; Sekita S; Satake M; Hirayama Y; Hakamata Y; Hayashi T; Yanagawa T
J Nat Prod; 1997 Oct; 60(10):997-1002. PubMed ID: 9358642
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
29. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, antiproliferative, acute toxicity and assessment of antiandrogenic activities of some newly synthesized steroidal lactams.
Dhingra N; Bhardwaj TR; Mehta N; Mukhopadhyay T; Kumar A; Kumar M
Eur J Med Chem; 2010 Jun; 45(6):2229-36. PubMed ID: 20171759
[TBL] [Abstract][Full Text] [Related]
31. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
32. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
33. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
[TBL] [Abstract][Full Text] [Related]
34. Novel selective anti-androgens with a diphenylpentane skeleton.
Maruyama K; Noguchi-Yachide T; Sugita K; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2010 Nov; 20(22):6661-6. PubMed ID: 20888766
[TBL] [Abstract][Full Text] [Related]
35. QSAR models for anti-androgenic effect--a preliminary study.
Jensen GE; Nikolov NG; Wedebye EB; Ringsted T; Niemela JR
SAR QSAR Environ Res; 2011 Mar; 22(1-2):35-49. PubMed ID: 21391140
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Woodhouse SL; Ziolkowski EJ; Rendina LM
Dalton Trans; 2005 Sep; (17):2827-9. PubMed ID: 16094469
[TBL] [Abstract][Full Text] [Related]
37. A novel 99mTc-labeled testosterone derivative as a potential agent for targeting androgen receptors.
Das T; Banerjee S; Samuel G; Bapat K; Subramanian S; Pillai MR; Venkatesh M
Bioorg Med Chem Lett; 2006 Nov; 16(22):5788-92. PubMed ID: 16949820
[TBL] [Abstract][Full Text] [Related]
38. New progesterone esters as antagonists of androgen receptors.
Cabeza M; Quiroz A; Bratoeff E; Heuze I; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():166-7. PubMed ID: 12434570
[No Abstract] [Full Text] [Related]
39. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Yamakoshi Y
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
